Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
20%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(1)
Other(4)

Detailed Status

unknown4
Completed1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

completed120%
unknown480%

Recent Activity

0 active trials
Showing 5 of 5
unknown

Shift Work Health Effects

NCT04813536
completed

Prognostic Biomarkers in Predicting Mortality in Respiratory Patients With Ventilator-Associated Pneumonia

NCT04739748
unknown

Management of Childhood Pancytopenia

NCT03521947
unknown

Lymphocyte Counts in Immune Thrombocytopenic Purpura

NCT03244410
unknownnot_applicable

Serum Interleukin -21 Level in Patients With Severe Adverse Cutaneous Drug Reaction.

NCT03166241

Clinical Trials (5)

Showing 5 of 5 trials
NCT04813536

Shift Work Health Effects

Unknown
NCT04739748

Prognostic Biomarkers in Predicting Mortality in Respiratory Patients With Ventilator-Associated Pneumonia

Completed
NCT03521947

Management of Childhood Pancytopenia

Unknown
NCT03244410

Lymphocyte Counts in Immune Thrombocytopenic Purpura

Unknown
NCT03166241Not Applicable

Serum Interleukin -21 Level in Patients With Severe Adverse Cutaneous Drug Reaction.

Unknown

All 5 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
5